Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China

Xiaoyun Yang1,2, Qian Liu1, Yuxin Fan1

  • 1Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.

Insights

Improved control of blood glucose, blood pressure, and lipids was observed in hospitalized type 2 diabetes patients. This study highlights progress in managing cardiovascular risk factors for inpatients over a five-year period.

Area of Science:

  • Endocrinology
  • Metabolism
  • Cardiovascular Medicine

Background:

  • Effective management of blood glucose, blood pressure, and lipids is crucial for type 2 diabetes patients to prevent cardiovascular disease and other complications.
  • Previous research primarily focused on outpatient settings, yielding suboptimal control rates.
  • Limited studies have investigated risk factor control specifically in hospitalized type 2 diabetes patients.

Purpose of the Study:

  • To assess the control rates of major cardiovascular risk factors in hospitalized patients with type 2 diabetes.
  • To evaluate the prevalence of microvascular and macrovascular complications in this patient cohort.
  • To track changes in risk factor control and complication prevalence over a five-year period.

Main Methods:

  • A retrospective analysis of 3,245 hospitalized type 2 diabetes patients from 2013 to 2017.
  • Calculation of percentages of patients meeting China Diabetes Society and American Diabetes Association goals for HbA1c, blood pressure, and blood lipids.
  • Assessment of the prevalence of major microvascular and macrovascular complications.

Main Results:

  • The percentage of patients meeting Chinese Diabetes Society goals for HbA1c, blood pressure, and lipids showed improvements between 2013 and 2017.
  • Achievement of all American Diabetes Association goals (HbA1c<7%, blood pressure <140/90 mmHg, LDL-C <2.6 mmol/L) increased from 4.3% to 9.0%.
  • Prevalence of major diabetes complications remained largely stable during the study period.

Conclusions:

  • Control rates for HbA1c, blood pressure, and low-density lipoprotein cholesterol improved in hospitalized type 2 diabetes patients in Tianjin, China, from 2013 to 2017.
  • Despite improvements in risk factor control, the prevalence of diabetes complications remained stable.
  • Further efforts are needed to optimize inpatient diabetes management and reduce complication rates.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
537
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
190
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
592